Zhao Gaofeng, Seng Jingjing, Beagle John, Syrkina Olga, Hales Charles A
Pulmonary and Critical Care Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Department of Surgery, First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Department of Surgery, First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Ann Thorac Surg. 2015 May;99(5):1677-84. doi: 10.1016/j.athoracsur.2014.12.061. Epub 2015 Mar 25.
Artery remodeling is the principal change of pulmonary artery hypertension. Heparin has been shown to inhibit vascular smooth muscle cell proliferation. We hypothesized that heparin may modulate vascular remodeling in pulmonary artery hypertension, and explored the mechanism.
A localized overcirculation-induced artery remodeling was created in piglets by anastomosing the left lower lobe pulmonary artery (LLLPA) to the thoracic aortic artery. Piglets were treated with heparin or saline for 4 weeks. Hemodynamic data were collected, and histology of the lung was assessed. We investigated the expressions of several candidate genes in lung and further observed the involvement of P38 mitogen-activated protein kinases (MAPK). The effects of heparin on the growth of cultured pulmonary arterial vascular smooth muscle cell and P38 MAPK expression were further determined under various conditions.
Four weeks after the shunt setup, overcirculation caused significant LLLPA remodeling, pressure increase, and pulmonary vascular resistance increase, and LLLPA flow reduction compared with that immediately after the shunt setup. Heparin reduced the LLLPA remodeling, pressure, and pulmonary vascular resistance, and increased the LLLPA flow compared with that not heparin treated. Shunt and heparin treatment did not change the piglet's systemic hemodynamics. Shunt increased the expression of P38 MAPK and heparin decreased its expression in the shunted LLLPA. Both heparin and P38 MAPK inhibitor suppressed VSMC growth and P38 MAPK expression in the cultured VSMC, but they did not present additive effects when the two treatments were combined.
Heparin reduces overcirculation-induced pulmonary artery remodeling through a P38 MAPK-dependent pathway.
动脉重塑是肺动脉高压的主要变化。肝素已被证明可抑制血管平滑肌细胞增殖。我们推测肝素可能调节肺动脉高压中的血管重塑,并探讨其机制。
通过将左下叶肺动脉(LLLPA)与胸主动脉吻合,在仔猪中建立局部过度循环诱导的动脉重塑。仔猪用肝素或生理盐水治疗4周。收集血流动力学数据,并评估肺组织学。我们研究了肺中几种候选基因的表达,并进一步观察了P38丝裂原活化蛋白激酶(MAPK)的参与情况。在各种条件下进一步确定肝素对培养的肺动脉血管平滑肌细胞生长和P38 MAPK表达的影响。
分流设置后4周,与分流设置后立即相比,过度循环导致LLLPA显著重塑、压力升高和肺血管阻力增加,以及LLLPA血流减少。与未用肝素治疗相比,肝素减少了LLLPA重塑、压力和肺血管阻力,并增加了LLLPA血流。分流和肝素治疗未改变仔猪的全身血流动力学。分流增加了P38 MAPK的表达,而肝素降低了分流的LLLPA中其表达。肝素和P38 MAPK抑制剂均抑制培养的VSMC中的VSMC生长和P38 MAPK表达,但两种治疗联合使用时未呈现相加效应。
肝素通过P38 MAPK依赖性途径减少过度循环诱导的肺动脉重塑。